Edition:
India

Teijin Ltd (3401.T)

3401.T on Tokyo Stock Exchange

2,240JPY
18 May 2018
Change (% chg)

¥17 (+0.76%)
Prev Close
¥2,223
Open
¥2,228
Day's High
¥2,246
Day's Low
¥2,219
Volume
885,000
Avg. Vol
1,245,157
52-wk High
¥2,603
52-wk Low
¥1,954

Latest Key Developments (Source: Significant Developments)

Teijin to merge with fiber unit
Thursday, 30 Nov 2017 

Nov 30(Reuters) - Teijin Ltd <3401.T>:Says it will merge with a Tokyo-based fiber consolidated subsidiary.Merger effective April 1, 2018.Says the subsidiary will be dissolved after the merger .  Full Article

R&I affirms Teijin's rating at "A-" and says stable outlook -R&I
Thursday, 16 Nov 2017 

Nov 16 (Reuters) - Teijin Ltd <3401.T>:Says Rating and Investment Information, Inc. (R&I) affirmed the company's rating at "A-" -R&I.Says rating outlook stable -R&I.  Full Article

Teijin lowers conversion price for 2018 due euro-yen denominated convertible bonds and 2021 due euro-yen denominated convertible bonds
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Teijin Ltd <3401.T>:Says it lowered the conversion price for 2018 due euro-yen denominated convertible bonds to 2,026 yen per share, from 2,035.7 yen per share, after Oct. 1 .Says it lowered the conversion price for 2021 due euro-yen denominated convertible bonds to 1,991.7 yen per share, from 2,001.3 yen per share, after Oct. 1 .  Full Article

Merz, Teijin announce partnership to bring Xeomin to Japan
Thursday, 12 Oct 2017 

Oct 12 (Reuters) - Teijin Ltd <3401.T>::Merz and Teijin announce partnership to bring Xeomin (Incobotulinumtoxina) to Japan.Entered into strategic license and co-development agreement with merz for commercialization of xeomin (incobotulinumtoxina) for Japan​.Merz sponsors 2 clinical trials in Japan covering spasticity of upper, lower limbs; upper limb trial completion seen in 2018​​.‍Under terms of agreement, Merz will receive an upfront payment in addition to milestones and royalties​.  Full Article

Teijin says co-sale of equity interests in film business joint ventures
Wednesday, 11 Oct 2017 

Oct 11 (Reuters) - Teijin Ltd <3401.T>:* Says it will jointly sell all of the.  Full Article

Teijin adjusts conversion prices for 2018 due and 2021 due euro-yen denominated convertible bonds with warrants
Wednesday, 2 Nov 2016 

Teijin Ltd <3401.T>: Says it adjusted the conversion price for 2018 due euro-yen denominated convertible bonds to 2,063.5 yen per share, from 2,069.0 yen per share, effective Oct. 1 .Says Adjusted the conversion price for 2021 due euro-yen denominated convertible bonds to 2,028.6 yen per share, from 2,034.0 yen per share, effective Oct. 1.  Full Article

R&I affirms Teijin Ltd's rating at "A-" and announces stable outlook -R&I
Monday, 31 Oct 2016 

Teijin Ltd <3401.T> : Rating and Investment Information, Inc. (R&I) affirmed the company's rating at "A-" -R&I .Rating outlook stable -R&I.  Full Article

Teijin to acquire DuPont stakes in Japan, Indonesia ventures - Nikkei
Saturday, 20 Aug 2016 

Nikkei: Japan's Teijin is set to make two polyester film joint ventures with Dupont into wholly owned subsidiaries - Nikkei .Teijin to acquire Dupont's 40% interest in Teijin Dupont Films Japan, take over Dupont's 49.9% stake in Indonesia Teijin Dupont Films - Nikkei.  Full Article

Teijin adjusts conversion price of 2018 due and 2021 due euro-yen denominated convertible bonds with warrants
Wednesday, 22 Jun 2016 

Teijin Ltd <3401.T> : Says the co adjusts the conversion price to 2,069.0 yen per share from 413.8 yen per share for the 2018 due euro-yen denominated convertible bonds with warrants . Says the co adjusts the conversion price to 2,034.0 yen per share from 406.8 yen per share for the 2021 due euro-yen denominated convertible bonds with warrants .Says adjustments with effective date from Oct. 1.  Full Article

BRIEF-SanBio and Teijin to terminate licensing agreement regarding SB623 for stroke treatment

* Says co and Teijin Limited would terminate the exclusive licensing agreement signed in 2009, regarding the development and marketing of SB623 for stroke treatment in Japan